CD8A and neoplasm: In summary, using 89Zr-IAB42M1-14 minibody PET imaging tracer, CD8+ T-cell recruitment following ICOS monotherapy and ICOS/PD-1 combination therapy was kinetically assessed in an EMT6 syngeneic mouse tumor model.